Skip to content

Innerspace, Inc.

United StatesFDA applicant, unverified

Devices
8

What Innerspace, Inc. makes

Innerspace, Inc. manufactures intracranial pressure (ICP) monitoring systems, ventricular catheters, and subdural drainage devices. The SYNERGY system and ACTI-ICP monitoring system provide real-time ICP measurement, while the ACT series (ACT II, ACT III, ACT 11 MP) includes ventricular catheters for cerebrospinal fluid drainage. The MPS and MPS-T systems, along with the MPS Oxiport and Oxiport Plus, support intracranial oxygen monitoring. Subdural drainage and ICP-only devices include the Hummingbird H900DS and H800S.

These devices are classified as Class II under FDA regulations and are authorised via the 510(k) pathway. The company’s products are listed in the FDA’s 510(k) registry. Innerspace, Inc. is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue8

Newest first, rows 1-8 of 8

Frequently asked questions

How many devices does Innerspace, Inc. have in the registry?

The registry currently lists 8 devices for Innerspace, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Innerspace, Inc.'s devices?

Among its 8 most recently registered devices, Innerspace, Inc. has devices listed in FDA 510(k) (8 devices).

What risk classes do Innerspace, Inc.'s devices fall under?

Among its 8 most recently registered devices, the classes recorded for Innerspace, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Innerspace, Inc. in the registry?

The most recently registered devices listed for Innerspace, Inc. include SYNERGY, ACTI-ICP MONITORING SYSTEM, ACT 11 MP VENTRICULAR CATHETER and MPS OXIPORT AND MPS OXIPORT PLUS.

Generated automatically from registry data and not verified by a human reviewer.